Aigen Investment Management LP Purchases New Stake in Procter & Gamble Company (The) (NYSE:PG)

Aigen Investment Management LP bought a new position in shares of Procter & Gamble Company (The) (NYSE:PG) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 6,410 shares of the company’s stock, valued at approximately $1,092,000.

A number of other institutional investors also recently bought and sold shares of the company. GAMMA Investing LLC increased its holdings in Procter & Gamble by 20,758.5% during the 1st quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company’s stock valued at $1,355,087,000 after acquiring an additional 7,913,335 shares in the last quarter. Capital Research Global Investors increased its holdings in Procter & Gamble by 62.5% during the 4th quarter. Capital Research Global Investors now owns 7,398,120 shares of the company’s stock valued at $1,240,294,000 after acquiring an additional 2,846,560 shares in the last quarter. Northern Trust Corp increased its holdings in Procter & Gamble by 10.1% during the 4th quarter. Northern Trust Corp now owns 29,395,208 shares of the company’s stock valued at $4,928,107,000 after acquiring an additional 2,703,757 shares in the last quarter. Invesco Ltd. increased its holdings in Procter & Gamble by 19.8% during the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock valued at $2,299,580,000 after acquiring an additional 2,228,151 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in Procter & Gamble by 15.8% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 16,274,563 shares of the company’s stock valued at $2,728,430,000 after acquiring an additional 2,224,912 shares in the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Procter & Gamble Price Performance

Shares of NYSE PG opened at $153.55 on Monday. Procter & Gamble Company has a fifty-two week low of $149.91 and a fifty-two week high of $180.43. The business has a 50 day moving average price of $158.26 and a two-hundred day moving average price of $163.66. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. The firm has a market cap of $359.67 billion, a PE ratio of 23.59, a price-to-earnings-growth ratio of 4.05 and a beta of 0.37.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.06. The company had revenue of $20.89 billion during the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The firm’s revenue for the quarter was up 1.7% compared to the same quarter last year. During the same period last year, the business earned $1.40 EPS. Sell-side analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 18th will be issued a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date of this dividend is Friday, July 18th. Procter & Gamble’s dividend payout ratio (DPR) is currently 64.98%.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on PG shares. Morgan Stanley set a $180.00 price objective on Procter & Gamble and gave the company an “overweight” rating in a research report on Friday, April 25th. Redburn Atlantic lowered Procter & Gamble from a “buy” rating to a “neutral” rating and set a $161.00 target price for the company. in a research note on Thursday, May 1st. Wells Fargo & Company dropped their target price on Procter & Gamble from $175.00 to $173.00 and set an “overweight” rating for the company in a research note on Wednesday, July 30th. Evercore ISI reiterated an “in-line” rating and issued a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Finally, Barclays set a $164.00 target price on Procter & Gamble and gave the company an “equal weight” rating in a research note on Thursday, July 31st. Seven equities research analysts have rated the stock with a hold rating, ten have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, Procter & Gamble presently has an average rating of “Moderate Buy” and a consensus target price of $175.88.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.